Pin Oak Investment Advisors Inc. purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 3,079 shares of the company’s stock, valued at approximately $396,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $25,000. Rakuten Securities Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter worth $27,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth $33,000. Delos Wealth Advisors LLC acquired a new position in shares of Merck KGaA during the second quarter worth $33,000. Finally, Burk Holdings LLC acquired a new position in shares of Merck KGaA during the second quarter worth $39,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $164.12 on Friday. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $21.21 billion, a PE ratio of 25.06 and a beta of 0.96. The business’s fifty day moving average price is $163.35 and its 200 day moving average price is $149.06.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
